Market Cap 105.63M
Revenue (ttm) 0.00
Net Income (ttm) -26.57M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 276,700
Avg Vol 1,052,920
Day's Range N/A - N/A
Shares Out 30.98M
Stochastic %K 14%
Beta 2.21
Analysts Strong Sell
Price Target $16.67

Company Profile

Skye Bioscience, Inc., a clinical stage biopharmaceutical company, focuses on developing molecules that modulate G protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in Jan...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 410 0266
Address:
11250 El Camino Real, Suite 100, San Diego, United States
rockytoday
rockytoday Aug. 4 at 8:39 PM
$SKYE $4 tomorrow
1 · Reply
Consistant1
Consistant1 Aug. 3 at 1:56 PM
$SKYE I am relieved I sold at $15 (inclusive of reverse split). I only lost 50%. Beware pump and dump, look at history of this stock. If I recall correctly I bought at $0.12, it went to $0.24 during peak of its weak 'glaucoma asset'. I should have sold, but thought nah let's see where she goes. It went south and glad I defined a 'must exit stratgy'. If I were still in this stock I would be down from 0.12 to 0.01 (83%).
0 · Reply
InvestInWhatYouKnow
InvestInWhatYouKnow Aug. 2 at 2:41 AM
$SKYE Nimacimab (JNJ-mab, SKYE holds worldwide ex-Asian rights since 25 Apr 2025) — humanized anti-IL-9 biologic. Two Phase-2 assets buried inside the same antibody..
1 · Reply
iLoveSqueezePlays
iLoveSqueezePlays Jul. 31 at 2:22 PM
$SKYE might be doubling my Position today. We shall see
0 · Reply
BIOTECH_GURU
BIOTECH_GURU Jul. 31 at 1:19 AM
$SKYE aye Viking!! You are a chameleon, I can't figure out if your in or out. 🤣
3 · Reply
MissionaryTrader
MissionaryTrader Jul. 30 at 6:54 PM
$SKYE NVO needs the next generation weight loss drug. All the stars are aligning, we just need good phase 2 results.
2 · Reply
John___wick44
John___wick44 Jul. 30 at 6:49 PM
$SKYE good ph2 data being bought out for 1.3 billion 30-40 a share
2 · Reply
iLoveSqueezePlays
iLoveSqueezePlays Jul. 30 at 5:50 PM
$SKYE been bullish on this for awhile. It’s just a matter of time imo
1 · Reply
MissionaryTrader
MissionaryTrader Jul. 30 at 4:28 PM
0 · Reply
DanishViking92
DanishViking92 Jul. 29 at 5:02 PM
$SKYE Get ready to reload the boat at $2
2 · Reply
Latest News on SKYE
Skye Bioscience, Inc. (SKYE) Q1 2025 Earnings Call Transcript

May 9, 2025, 7:20 PM EDT - 3 months ago

Skye Bioscience, Inc. (SKYE) Q1 2025 Earnings Call Transcript


Skye Bioscience to Conduct Meetings at Piper Sandler Conference

Apr 14, 2025, 7:00 AM EDT - 4 months ago

Skye Bioscience to Conduct Meetings at Piper Sandler Conference


Skye Bioscience, Inc. (SKYE) Q4 2024 Earnings Call Transcript

Mar 20, 2025, 9:58 PM EDT - 4 months ago

Skye Bioscience, Inc. (SKYE) Q4 2024 Earnings Call Transcript


Skye Bioscience to Present at TD Cowen Health Care Conference

Feb 20, 2025, 7:00 AM EST - 5 months ago

Skye Bioscience to Present at TD Cowen Health Care Conference


Skye Bioscience Announces Participation in February Conferences

Feb 4, 2025, 7:00 AM EST - 6 months ago

Skye Bioscience Announces Participation in February Conferences


MoneyShow's Best Investment Ideas For 2025: Part 8

Feb 3, 2025, 9:20 AM EST - 6 months ago

MoneyShow's Best Investment Ideas For 2025: Part 8

DELL FNV MNKD MSTR SKE AMSC


Skye Bioscience to Present at J.P. Morgan Healthcare Conference

Dec 19, 2024, 7:00 AM EST - 8 months ago

Skye Bioscience to Present at J.P. Morgan Healthcare Conference


Skye Bioscience, Inc. (SKYE) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 10:36 PM EST - 9 months ago

Skye Bioscience, Inc. (SKYE) Q3 2024 Earnings Call Transcript


Skye Bioscience to Announce Third Quarter 2024 Results

Nov 1, 2024, 7:00 AM EDT - 9 months ago

Skye Bioscience to Announce Third Quarter 2024 Results


Skye: Moving Weight Loss Drugs To The Next Level

Sep 4, 2024, 11:26 AM EDT - 11 months ago

Skye: Moving Weight Loss Drugs To The Next Level


rockytoday
rockytoday Aug. 4 at 8:39 PM
$SKYE $4 tomorrow
1 · Reply
Consistant1
Consistant1 Aug. 3 at 1:56 PM
$SKYE I am relieved I sold at $15 (inclusive of reverse split). I only lost 50%. Beware pump and dump, look at history of this stock. If I recall correctly I bought at $0.12, it went to $0.24 during peak of its weak 'glaucoma asset'. I should have sold, but thought nah let's see where she goes. It went south and glad I defined a 'must exit stratgy'. If I were still in this stock I would be down from 0.12 to 0.01 (83%).
0 · Reply
InvestInWhatYouKnow
InvestInWhatYouKnow Aug. 2 at 2:41 AM
$SKYE Nimacimab (JNJ-mab, SKYE holds worldwide ex-Asian rights since 25 Apr 2025) — humanized anti-IL-9 biologic. Two Phase-2 assets buried inside the same antibody..
1 · Reply
iLoveSqueezePlays
iLoveSqueezePlays Jul. 31 at 2:22 PM
$SKYE might be doubling my Position today. We shall see
0 · Reply
BIOTECH_GURU
BIOTECH_GURU Jul. 31 at 1:19 AM
$SKYE aye Viking!! You are a chameleon, I can't figure out if your in or out. 🤣
3 · Reply
MissionaryTrader
MissionaryTrader Jul. 30 at 6:54 PM
$SKYE NVO needs the next generation weight loss drug. All the stars are aligning, we just need good phase 2 results.
2 · Reply
John___wick44
John___wick44 Jul. 30 at 6:49 PM
$SKYE good ph2 data being bought out for 1.3 billion 30-40 a share
2 · Reply
iLoveSqueezePlays
iLoveSqueezePlays Jul. 30 at 5:50 PM
$SKYE been bullish on this for awhile. It’s just a matter of time imo
1 · Reply
MissionaryTrader
MissionaryTrader Jul. 30 at 4:28 PM
0 · Reply
DanishViking92
DanishViking92 Jul. 29 at 5:02 PM
$SKYE Get ready to reload the boat at $2
2 · Reply
Tikdok
Tikdok Jul. 29 at 3:56 PM
$SKYE The bar is pretty low for nimacimab to clear. Aside from any level of statistically significant weight loss, if it shows an improvement in lean mass preservation in the wegovy arm, it would be a huge win.
1 · Reply
MissionaryTrader
MissionaryTrader Jul. 29 at 11:46 AM
$SKYE https://www.cnbc.com/2025/07/29/novo-nordisk-shares-plunge-after-wegovy-maker-cuts-full-year-guidance-.html
2 · Reply
Bruticus
Bruticus Jul. 28 at 4:26 PM
$SKYE see y’all at 2.00
2 · Reply
aricray
aricray Jul. 28 at 3:26 AM
$CAPR $SOUN $SKYE $NBIS Is it just me or are day-traders LAF?
0 · Reply
rockytoday
rockytoday Jul. 25 at 12:31 PM
$SKYE $3.88 today
2 · Reply
Fellforit
Fellforit Jul. 24 at 7:04 PM
$SKYE. Im sure Dhillon's phone is ringing off the hook with gigantic offers from big pharma!!! Just like the glaucoma days.. Someday the unbelievable might happen!!!
3 · Reply
WavRyder
WavRyder Jul. 24 at 2:45 PM
$SKYE who was pumping it yesterday?
0 · Reply
leis5
leis5 Jul. 23 at 8:21 PM
$SKYE All you need to know https://beyondspx.com/article/skye-bioscience-unlocking-peripheral-cb1-inhibition-in-the-obesity-arms-race-skye
0 · Reply
MMKalco
MMKalco Jul. 23 at 8:02 PM
$NIO $ATNM $PFE $SKYE Sheeeeeeeeeshhh
0 · Reply
YazzJr
YazzJr Jul. 23 at 7:27 PM
$SKYE Well if this proves to be similar move to what happened in Feb 2024 then a big green candle is on the horizon. The Bollinger bands are squeezed together suggesting a big move up might be close. Now I know history doesn't always repeat but, sometimes it does rhyme. So let' see. Maybe we get data earlier than expected.
0 · Reply
jackedmund99
jackedmund99 Jul. 23 at 4:04 PM
$SKYE there’s gotta be something someplace on this what’s the news?
0 · Reply
leis5
leis5 Jul. 23 at 4:03 PM
$SKYE what’s happening?
1 · Reply